Targeting bile‐acid signalling for metabolic diseases
Open accessThe DOI matches its Crossref record; 165 of the 169 references it cites were found in a registry or an index.
Abstract
Bile acids are increasingly being appreciated as complex metabolic integrators and signalling factors and not just as lipid solubilizers and simple regulators of bile-acid homeostasis. It is therefore not surprising that a number of bile-acid-activated signalling pathways have become attractive therapeutic targets for metabolic disorders. Here, we review how the signalling functions of bile acids can be exploited in the development of drugs for obesity, type 2 diabetes, hypertriglyceridaemia and atherosclerosis, as well as other associated chronic diseases such as non-alcoholic steatohepatitis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Through FXR activation, OCA modulates bile acid synthesis, absorption, transport, secretion, and metabolism, with a net effect of choleresis.(157,158)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [157]
In the citing paper
“In animal models, FXR activation has demonstrated antifibrotic and anti-inflammatory properties as well.(157)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [157]
In the citing paper
“After conjugation with either taurine or glycine, primary bile acids are released into the intestine to assist with lipid digestion and are recycled back into the liver (Thomas et al., 2008).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2008
In the citing paper
“By activating nuclear farnesoid X receptor (FXR) and plasma membrane TGR5 receptor, bile acids were shown to regulate systemic lipid, cholesterol, and glucose metabolism, as well as energy and immune homeostasis (Calmus and Poupon, 2014;de Aguiar Vallim et al., 2013;Thomas et al., 2008).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2008
In the citing paper
“In addition, FXR regulates other pathways with direct antiinflammatory and antifibrotic effects. 13-15”
From A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis (2016) · cites this paper as [13]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Self-citationThe Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
Research works printed but not linked: 1
- Harnish, D. C. et al. A synthetic farnesoid X receptor (FXR) agonist protects against diet-induced dyslipidemia. J. Clin. Lipidol. 1, 362 (2007).
Cited by
Items 201–300 of 1,002
Wang, G., Huang, W., Xia, Y., Xiong, Z., & Ai, L. (2019) · Food & Function · doi:10.1039/c8fo02181c · Cited by 118
Wegner, K., Just, S., Gau, L., Henrike, M., Gérard, P., Lepage, P., Clavel, T., & Rohn, S. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-0048-1 · Cited by 124
Xu, M., Cen, M., Shen, Y. S., Zhu, Y., Cheng, F., Tang, L., Hu, W., & Dai, N. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06208-3 · Cited by 127
“OSTα and OSTβ, which are proteins that are related to the intracellular binding and basolateral secretion of bile acid, can also be induced by ileal FXR [34].”
BackgroundConjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis
Xie, G., Jiang, R., Wang, X., Liu, P., Zhao, A., Wu, Y., Huang, F., Liu, Z., Rajani, C., Zheng, X., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103290 · Cited by 129
“As important signaling molecules, BAs play a critical role in the regulation of hepatic metabolic homeostasis by activating or inhibiting nuclear farnesoid X receptor (FXR) and membrane G-protein-coupled receptor (TGR5) [10,11].”
BackgroundGoldberg, A. A., Richard, V. R., Kyryakov, P., Bourque, S. D., Beach, A., Burstein, M. T., Glebov, A., Koupaki, O., Boukh-Viner, T., Gregg, C., et al. (2010) · Aging · doi:10.18632/aging.100168 · Cited by 118
“signaling pathway that 1) enhances energy expenditure in brown adipose tissue and muscle by stimulating mitochondrial oxidative phosphorylation and uncoupling; 2) improves liver and pancreatic function by activating the endothelial nitric oxide synthase; and 3) enhances glucose tolerance in obese mice by inducing inte…”
BackgroundInfluentialMetabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes
Bakar, M. H. A., Sarmidi, M. R., Cheng, K., Khan, A. A., Suan, C. L., Huri, H. Z., & Yaakob, H. (2015) · Molecular BioSystems · doi:10.1039/c5mb00158g · Cited by 129
Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review
Kimhofer, T., Fye, H. K. S., Taylor-Robinson, S. D., Thursz, M. R., & Holmes, E. C. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.38 · Cited by 122
“Some of the bile acids have also been described as versatile signalling molecules (Thomas et al, 2008, 2009; Gadaleta et al, 2011), for instance, lithocholic acid and DCA are both involved in the promotion of energy expenditure and participation in glucidic metabolism by acting on the…”
BackgroundCurrent trials and novel therapeutic targets for alcoholic hepatitis
Singal, A. K., & Shah, V. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.026 · Cited by 117
Huang, S., Pang, D., Li, X., You, L., Zhao, Z., Cheung, P. C. K., Zhang, M., & Liu, D. (2019) · Food & Function · doi:10.1039/c9fo00263d · Cited by 122
Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling
Wahlström, A., Kovatcheva-Datchary, P., Ståhlman, M., Bäckhed, F., & Marschall, H.-U. (2017) · Digestive Diseases · doi:10.1159/000450982 · Cited by 115
Schnabl, B., Damman, C. J., & Carr, R. M. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186423 · Cited by 142
Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells
Goldberg, A. A., Beach, A., Davies, G. F., Harkness, T. A. A., LeBlanc, A. C., & Titorenko, V. I. (2011) · Oncotarget · doi:10.18632/oncotarget.338 · Cited by 119
“The resulting changes in mitochondria may include such welldocumented effects of LCA as MOMP activation and elevated ROS production [169,170,176-178].”
Nuclear Receptors as New Perspective for the Management of Liver Diseases
Trauner, M., & Halilbasic, E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.044 · Cited by 118
Guo, J., Han, X., Tan, H., Huang, W., You, Y., & Zhan, J. (2019) · iScience · doi:10.1016/j.isci.2019.08.020 · Cited by 118
“The activation of TGR5 induces the intracellular accumulation of cyclic AMP, followed by the downstream activation of its signaling pathways, such as the activation of D2 (Thomas et al., 2008).”
BackgroundRole of farnesoid X receptor and bile acids in alcoholic liver disease
Manley, S., & Ding, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.12.011 · Cited by 112
Omar, J. M., Chan, Y.-M., Jones, M. L., Prakash, S., & Jones, P. J. H. (2013) · Journal of Functional Foods · doi:10.1016/j.jff.2012.09.001 · Cited by 110
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents
Hasegawa, S., Yoneda, M., Kurita, Y., Nogami, A., Honda, Y., Hosono, K., & Nakajima, A. (2021) · Drugs · doi:10.1007/s40265-021-01545-7 · Cited by 125
“Through FXR activation, OCA modulates bile acid synthesis, absorption, transport, secretion, and metabolism, with a net effect of choleresis [39, 45].”
BackgroundTissue-specific actions of FXR in metabolism and cancer
Gadaleta, R. M., Cariello, M., Sabbà, C., & Moschetta, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.005 · Cited by 118
Bush, K. T., Wu, W., Lun, C., & Nigám, S. K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.796516 · Cited by 117
“In addition, bile acids are now recognized as versatile signaling molecules based primarily on their ability to act as ligands for G protein-coupled receptors, such as the membrane receptor TGR5, as well as nuclear receptors like the farnesoid X receptor (65, 75, 76).”
BackgroundMellitzer, G., Beucher, A., Lobstein, V., Michel, P., Robine, S., Kedinger, M., & Gradwohl, G. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40794 · Cited by 110
“In addition, there is increasing evidence that bile acids also affect energy and glucose homeostasis (39, 40).”
BackgroundWan, Y., Yuan, J., Li, J., Li, H., Zhang, J., Tang, J., Ni, Y., Huang, T., Wang, F., Zhao, F., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.02.037 · Cited by 119
Kemper, J. K. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.11.011 · Cited by 106
Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cells
Goldberg, A. A., Titorenko, V. I., Beach, A., & Sanderson, J. T. (2013) · PeerJ · doi:10.7717/peerj.122 · Cited by 106
Liu, T., Song, X., Khan, S., Li, Y., Guo, Z., Li, C., Wang, S., Dong, W., Liu, W., Wang, B., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32563 · Cited by 109
“Three main roles are proposed for GPBAR1, including involvement in the physiology of the liver and gallbladder, modulating metabolism and immunity.(83) Little studies have focused on the role of GPBAR1 in CRC.”
BackgroundNonalcoholic fatty liver disease – current status and future directions
Demir, M., Lang, S., & Steffen, H. (2015) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12291 · Cited by 105
Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis
Simbrunner, B., Trauner, M., & Reiberger, T. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16602 · Cited by 114
Ulrich-Lai, Y. M., & Ryan, K. K. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.020 · Cited by 104
“Other peripheral strategies in varying phases of development include targeting intestinal digestion and uptake of lipids (e.g., Orlistat and Cetilistat) (Kopelman et al., 2010; Torgerson et al., 2004), bile acid signaling (Thomas et al., 2008), and BAT thermogenesis (Frühbeck et al., 2009).”
Vettorazzi, J. F., Ribeiro, R. A., Borck, P. C., Branco, R. C. S., Soriano, S., Merino, B., Boschero, A. C., Nadal, A., Quesada, I., & Carneiro, E. M. (2016) · Metabolism · doi:10.1016/j.metabol.2015.10.021 · Cited by 104
Physiological Role of Bile Acids Modified by the Gut Microbiome
Kiriyama, Y., & Nochi, H. (2021) · Microorganisms · doi:10.3390/microorganisms10010068 · Cited by 112
“BSEP is the predominant transporter of BAs from hepatocytes to the bile canaliculi [3,13].”
BackgroundMouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15
Zhou, M., Luo, J., Chen, M., Yang, H., Learned, R. M., DePaoli, A. M., Tian, H., & Ling, L. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.027 · Cited by 102
Udayappan, S. D., Hartstra, A. V., Dallinga-Thie, G. M., & Nieuwdorp, M. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12293 · Cited by 101
Magotti, P., Bauer, I., Igarashi, M., Babagoli, M. A., Marotta, R., Piomelli, D., & Garau, G. (2015) · Structure · doi:10.1016/j.str.2014.12.018 · Cited by 109
“In mammals, they also serve, however, important signaling functions in cholesterol and glucose homeostasis by activating G protein-coupled membrane receptors (e.g. TGR5) (Thomas et al, 2008; Thomas et al, 2009) and nuclear receptors (e.g. FXR) (Parks et al., 1999; MI et al., 2003).”
Miyazaki‐Anzai, S., Levi, M., Kratzer, A., Ting, T. C., Lewis, L., & Miyazaki, M. (2010) · Circulation Research · doi:10.1161/circresaha.109.212969 · Cited by 103
Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice
Zhang, X., Huang, S., Gao, M., Liu, J., Jia, X., Han, Q., Zheng, S., Miao, Y., Li, S., Weng, H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323977111 · Cited by 106
Critical roles of bile acids in regulating intestinal mucosal immune responses
Sun, R., Xu, C., Feng, B., Gao, X., & Liu, Z. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211018098 · Cited by 118
Moreno-Indias, I., Sánchez-Alcoholado, L., Sánchez-Garrido, M. Á., Martín-Núñez, G. M., Pérez-Jiménez, F., Tena-Sempere, M., Tinahones, F. J., & Queipo-Ortuño, M. I. (2016) · Endocrinology · doi:10.1210/en.2016-1317 · Cited by 100
Repeated sleep disruption in mice leads to persistent shifts in the fecal microbiome and metabolome
Bowers, S. J., Vargas, F., González, A., He, S., Jiang, P., Dorrestein, P. C., Knight, R. D., Wright, K. P., Lowry, C. A., Fleshner, M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229001 · Cited by 105
“In the intestine, primary bile acids are dehydroxylated and deconjugated by the gut microbiome, creating secondary bile acids and greatly enhancing the diversity of the bile acid pool[78].”
BackgroundVersatile Triad Alliance: Bile Acid, Taurine and Microbiota
Duszka, K. (2022) · Cells · doi:10.3390/cells11152337 · Cited by 110
Regulation of bile acids and their receptor FXR in metabolic diseases
Li, Y., Wang, L., Qing, Y., Luo, L., & Xiong, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1447878 · Cited by 126
Steinert, R. E., & Beglinger, C. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.02.039 · Cited by 116
Vanwijngaerden, Y.-M., Wauters, J., Langouche, L., Vander Perre, S., Liddle, C., Coulter, S., Vanderborght, S., Roskams, T., Wilmer, A., Van den Berghe, G., et al. (2011) · Hepatology · doi:10.1002/hep.24582 · Cited by 96
de Sousa, L. Q., Machado, K. D. C., Oliveira, S. F. D. C., Araújo, L. D. S., Filho, E. D. S. M., Cavalcante, A. A. D. C. M., Júnior, G. M. V., & Ferreira, P. M. P. (2017) · Toxicon · doi:10.1016/j.toxicon.2017.01.004 · Cited by 101
De Novo Synthesis of Steroids and Oxysterols in Adipocytes
Li, J., Daly, E., Campioli, E., Wabitsch, M., & Papadopoulos, V. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534172 · Cited by 95
“This conclusion was further supported by the absence of Tgr5 and Fxr mRNA, two major targets of bile acid-modulated effects (25), in 3T3-L1 cells throughout differentiation (data not shown).”
BackgroundHolmes, Z. C., Silverman, J. D., Dressman, H. K., Wei, Z., Dallow, E. P., Armstrong, S., Seed, P. C., Rawls, J. F., & David, L. A. (2020) · mBio · doi:10.1128/mbio.00914-20 · Cited by 115
“Multiple mechanisms for this link have been proposed, including increased energy harvest by obese microbiota (10), activation of enteroendocrine signaling pathways by short-chain fatty acids (SCFAs) (11–13), modulation of glucose and energy homeostasis through bile acid signaling (14), and increased local and systemic…”
Molecular features of bile salt hydrolases and relevance in human health
Chand, D., Avinash, V. S., Yadav, Y., Pundle, A. V., Suresh, C. G., & Ramasamy, S. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.024 · Cited by 107
Molecular Control of Systemic Bile Acid Homeostasis by the Liver Glucocorticoid Receptor
Rose, A. J., Díaz, M. B., Reimann, A., Klement, J., Walcher, T., Krones, A., Strobel, O., Werner, J. M., Peters, A., Kleyman, A., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.010 · Cited by 96
The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways
Jiang, D., Chen, S., Sun, R., Zhang, X., & Wang, D. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.034 · Cited by 102
Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice
Fan, Y., Lu, H., Guo, Y., Zhu, T., Garcia-Barrio, M. T., Jiang, Z., Willer, C. J., Zhang, J., & Chen, Y. E. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.005 · Cited by 92
“The increases in TC and LDL-c in TM6SF2 transgenic mice may be attributed, amongst other factors, to altered bile acid metabolism, lipoprotein and cholesterol biosynthesis.(16) Noteworthy, some bile acid and cholesterol related genes were dysregulated in livers of the Alb-TM6SF2 mice (Figure 1E).”
Dawson, P. A., Hubbert, M. L., & Rao, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.06.002 · Cited by 92
“This section briefly highlights the major transporters and mechanisms involved in the enterohepatic circulation of bile acids and regulation of their hepatic synthesis, subjects that have recently been reviewed in detail [11–15].”
Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling
Keune, W., Hausmann, J., Bolier, R., Tolenaars, D., Kremer, A. E., Heidebrecht, T., Joosten, R. P., Sunkara, M., Morris, A. J., Matas-Rico, E., et al. (2016) · Nature Communications · doi:10.1038/ncomms11248 · Cited by 98
“More specifically developments have targeted obesity, type 2 diabetes, hypertriglyceridaemia and atherosclerosis 32 .”
Lau, L. H. S., & Wong, S. H. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_9 · Cited by 104
Bile Acid Sequestrants for Lipid and Glucose Control
Staels, B., Handelsman, Y., & Fonseca, V. A. (2010) · Current Diabetes Reports · doi:10.1007/s11892-009-0087-5 · Cited by 108
“[51].”
The Fox Genes in the Liver: From Organogenesis to Functional Integration
Lay, J. E. L., & Kaestner, K. H. (2010) · Physiological Reviews · doi:10.1152/physrev.00018.2009 · Cited by 104
“More recently, bile acids have been shown to be critical regulators of glucose metabolism and energy expenditure (179).”
BackgroundZhai, Q., Liu, Y., Wang, C., Qu, D., Zhao, J., Zhang, H., Tian, F., & Chen, W. (2019) · Food & Function · doi:10.1039/c8fo02554a · Cited by 95
Chen, Y., Le, T. H., Du, Q., Zhao, Z., Liu, Y., Zou, J., Hua, W., Liu, C., & Zhu, Y. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.021 · Cited by 92
Busnelli, M., Manzini, S., & Chiesa, G. (2019) · Nutrients · doi:10.3390/nu12010079 · Cited by 98
“In hepatocytes, the biosynthesis of the two primary BAs, cholic acid (CA) and chenodeoxycholic acid (CDCA), occurs via two different series of enzymatic reactions: the classical pathway, initiated by the enzyme cholesterol 7a-hydroxylase (CYP7A1), and the alternative pathway initiated by sterol-27-hydroxylase (CYP27A1…”
BackgroundLiver Physiology: Metabolism and Detoxification
Chiang, J. Y. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.04202-7 · Cited by 132
Lu, J., Wang, S., Li, M., Gao, Z., Xu, Y., Zhao, X., Hu, C., Zhang, Y., Liu, R., Hu, R., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0884 · Cited by 99
Li, S., Hsu, D. D. F., Li, B., Luo, X., Alderson, N., Qiao, L., Ma, L., Zhu, H. H., He, Z., Suino-Powell, K., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.020 · Cited by 90
“Ileum is the major site for BA reabsorption in the intestine (Baker and Searle, 1960; Buchwald and Gebhard, 1968; Thomas et al., 2008).”
A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease
Greenberg, N., Grassano, A., Thambisetty, M., Lovestone, S., & Legido‐Quigley, C. (2009) · ELECTROPHORESIS · doi:10.1002/elps.200800589 · Cited by 89
Ursodeoxycholic acid accelerates bile acid enterohepatic circulation
Zhang, Y., Jiang, R., Zheng, X., Lei, S., Huang, F., Xie, G., Kwee, S. A., Yu, H., Farrar, C. E., Sun, B., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14705 · Cited by 95
“…BA transporters, such as multidrug resistance‐associated protein 3 (MRP3), multidrug resistance‐associated protein 4 (MRP4), organic anion transporting polypeptide 2 (OATP2, Slco1a4), and OSTα/β, can transport excess BAs to the systemic circulation (Halilbasic et al., 2013; Thomas et al., 2008).”
BackgroundResultDetermination of bile salt critical micellization concentration on the road to drug discovery
Natalini, B., Sardella, R., Gioiello, A., Ianni, F., Michele, A. D., & Marinozzi, M. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.06.029 · Cited by 88
“Over the last 10 years, the importance of bile acids (BAs) and heir derivatives has increased considerably in both basic science nd clinical applications for several reasons [1,2].”
BackgroundBile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease
Li, T., & Chiang, J. Y. L. (2020) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2019.09.03 · Cited by 91
“Several bile acid-based therapies have been investigated in clinical trials for NASH treatment and will be reviewed here (103-115).”
BackgroundThe functions of gut microbiota-mediated bile acid metabolism in intestinal immunity
He, Y., Shaoyong, W., Chen, Y., Li, M., Gan, Y., Sun, L., Liu, Y., Wang, Y., & Jin, M. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.015 · Cited by 124
“The development of FXR agonists is beneficial for reducing liver and serum triglyceride levels in disorders like metabolic syndrome, while also preventing intestinal bacteria overgrowth [10].”
InfluentialLiu, H., Tian, R., Wang, H., Feng, S., Li, H., Xiao, Y., Luan, X., Zhang, Z., Shi, N., Niu, H., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02539-x · Cited by 91
“The gut microbiota regulates the expression of hepatic enzymes involved in bile acids synthesis, including Cyp7a1, Cyp27a1 and Cyp7b1, where Cyp7a1 is a rate-limiting enzyme for bile acid synthesis [31].”
BackgroundSandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury
Yang, K., Guo, C., Woodhead, J. L., St. Claire, R. L., Watkins, P. B., Siler, S. Q., Howell, B. A., & Brouwer, K. L. R. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.008 · Cited by 85
Paxton, J. W. (2012) · InTech eBooks · doi:10.5772/1180 · Cited by 96
Xu, J., Xie, S., Chi, S., Zhang, S., Cao, J., & Tan, B. (2022) · Food & Function · doi:10.1039/d1fo04085e · Cited by 85
Bortolussi, G., Zentillin, L., Vaníkova, J., Bockor, L., Bellarosa, C., Mancarella, A., Vianello, E., Tiribelli, C., Giacca, M., Vitek, L., et al. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.233 · Cited by 85
“Normally, these steps are performed by active transporters in the liver (Kamisako et al., 2000; Thomas et al., 2008).”
BackgroundCummings, B. P., Bettaieb, A., Graham, J. L., Stanhope, K. L., Kowala, M., Haj, F. G., Chouinard, M. L., & Havel, P. J. (2012) · Endocrinology · doi:10.1210/en.2012-1131 · Cited by 85
“Bile acids have been shown to decrease hepatic gluconeogenesis and lipogenesis and increase insulin-mediated glucose disposal in adipocytes by signaling through farnesoid X receptor (42).”
BackgroundEmerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
Musso, G., Gambino, R., & Cassader, M. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101107.134820 · Cited by 86
Obesity and Asthma: Microbiome–Metabolome Interactions
Shore, S. A., & Cho, Y. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0052ps · Cited by 90
“In the liver, bile acid-induced activation of FXR results in reduced fatty acid synthesis and decreases circulating triglycerides (120).”
BackgroundStepanov, V., Stankov, K., & Mikov, M. (2013) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2013.802805 · Cited by 83
Zhang, G., Wang, Q., Tao, W., Jiang, W., Elinav, E., Wang, Y., & Zhu, S. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00903-4 · Cited by 86
Host metabolism balances microbial regulation of bile acid signalling
Won, T. H., Arifuzzaman, M., Parkhurst, C. N., Miranda, I. C., Zhang, B., Hu, E., Kashyap, S., Letourneau, J., Jin, W., Fu, Y., et al. (2025) · Nature · doi:10.1038/s41586-024-08379-9 · Cited by 108
Lewis, N. D., Patnaude, L. A., Pelletier, J., Souza, D. J., Lukas, S. M., King, F. J., Hill, J. D., Stefanopoulos, D. E., Ryan, K., Desai, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100883 · Cited by 84
“Consequently, development of specific GPBAR1 agonists for the treatment of diabetes and obesity has been an area of very active research [2,3].”
BackgroundLithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation
Giorgio, C., Hassan Mohamed, I., Flammini, L., Barocelli, E., Incerti, M., Lodola, A., & Tognolini, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018128 · Cited by 83
“In fact modulation of the pharmacophore elements present in bile acids could provide high affinity binding molecules, as previously testified by the development of TGR5 and FXR agonists [34].”
BackgroundVignozzi, L., Morelli, A., Filippi, S., Comeglio, P., Chavalmane, A. K., Marchetta, M., Toce, M., Yehiely-Cohen, R., Vannelli, G. B., Adorini, L., et al. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02073.x · Cited by 83
The bridge of the gut–joint axis: Gut microbial metabolites in rheumatoid arthritis
Xu, X., Wang, M., Wang, Z., Chen, Q., Chen, X., Xu, Y., Dai, M., Wu, B., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1007610 · Cited by 105
“CDCA, a BA breakdown product, can activate FXR, increase alkaline phosphatase activity and extracellular matrix calcification, and stimulate the expression of osteoblast marker genes (bone sialoprotein (BSP), osteocalcin (OC), osteopontin (OPN) and alkaline phosphatase (ALP)) and the DNA-binding activity of the bone t…”
BackgroundInfluentialRole of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD
Fuchs, C. D., Claudel, T., & Trauner, M. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.08.001 · Cited by 91
Ferrandi, E. E., Bertolesi, G. M., Polentini, F., Negri, A. L., Riva, S., & Monti, D. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3798-x · Cited by 86
Vassileva, G., Hu, W., Hoos, L., Tetzloff, G., Yang, S., Liu, L., Kang, L., Davis, H. R., Hedrick, J. A., Lan, H., et al. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0009 · Cited by 82
Rajagopal, S., Kumar, D. P., Mahavadi, S., Bhattacharya, S., Zhou, R., Corvera, C. U., Bunnett, N. W., Grider, J. R., & Murthy, K. S. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00388.2012 · Cited by 81
Perspectives on Treatment for Nonalcoholic Steatohepatitis
Lassailly, G., Caiazzo, R. J., Pattou, F. N., & Mathurin, P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.004 · Cited by 94
Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?
Martín‐Núñez, G. M., Cornejo-Pareja, I. M., Clemente‐Postigo, M., & Tinahones, F. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.639856 · Cited by 97
The interrelationship between bile acid and vitamin A homeostasis
Saeed, A., Hoekstra, M., Hoeke, M. O., Heegsma, J., & Faber, K. N. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.01.007 · Cited by 96
Sanyal, A. J., Ling, L., Beuers, U., DePaoli, A. M., Lieu, H. D., Harrison, S. A., & Hirschfield, G. M. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100255 · Cited by 79
Bile acids in drug induced liver injury: Key players and surrogate markers
Schadt, H. S., Wolf, A., Pognan, F., Chibout, S., Merz, M., & Kullak-Ublick, G. A. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.12.017 · Cited by 86
“BAs escaping intestinal absorption are excreted via feces accounting for about 10 to 20 % loss per day [7], fecal BAs being mainly secondary BAs.”
BackgroundMorelli, A., Comeglio, P., Filippi, S., Sarchielli, E., Cellai, I., Vignozzi, L., Yehiely-Cohen, R., Maneschi, E., Gacci, M., Carini, M., et al. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.02.007 · Cited by 84
Mechanism of Hydrophobic Bile Acid-Induced Hepatocyte Injury and Drug Discovery
Wei, S., Ma, X., & Zhao, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01084 · Cited by 83
Briere, D. A., Ruan, X., Cheng, C. C., Siesky, A. M., Fitch, T. E., Dominguez, C., Sanfeliciano, S. G., Montero, C., Suen, C. S., Xu, Y., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136873 · Cited by 78
“In addition to their stimulation of hormone secretion, lipids in the diet also cause the release of bile acids from the gallbladder that help facilitate processing of dietary fat and fat soluble vitamins [10].”
BackgroundPresence of gallstones and the risk of cardiovascular diseases: The EPIC-Germany cohort study
Wirth, J., di Giuseppe, R., Wientzek, A., Katzke, V. A., Kloß, M., Kaaks, R., Boeing, H., & Weikert, C. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313512218 · Cited by 78
Safaei, A., Oskouie, A. A., Mohebbi, S. R., Rezaei–Tavirani, M., Mahboubi, M., Peyvandi, M., Okhovatian, F., & Azodi, M. Z. (2016) · Gastroenterology and hepatology from bed to bench. · Cited by 96
Xiao, Y., Zhou, K., Lu, Y., Yan, W., Cai, W., & Wang, Y. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0181-3 · Cited by 83
Bile acid-mediated signaling in cholestatic liver diseases
Zeng, J., Fan, J., & Zhou, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01035-1 · Cited by 84
Lee, J., Seok, S., Yu, P., Kim, K., Smith, Z., Rivas‐Astroza, M., Zhong, S., & Kemper, J. K. (2012) · Hepatology · doi:10.1002/hep.25609 · Cited by 81
Yao, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14430 · Cited by 78
Choucair, I., Nemet, I., Li, L., Cole, M. A., Skye, S. M., Kirsop, J. D., Fischbach, M. A., Gogonea, V., Brown, J. M., Tang, W. H. W., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000311 · Cited by 77
“As increasing awareness in the involvement of BA in disease-relevant processes has occurred, there is in parallel increased interest in the use of BAs for risk stratification for therapeutic decisions (47) and for BA pathways for becoming targets for pharmacotherapy for a variety of cardiometabolic diseases (48).”
BackgroundDetection technologies and metabolic profiling of bile acids: a comprehensive review
Liu, Y., Rong, Z., Xiang, D., Zhang, C., & Liu, D. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0774-9 · Cited by 83
“Besides, BAs are involved in the regulation of G-protein-coupled BA receptor (TGR5), which play key roles in stimulating energy metabolism, reducing liver and intestinal inflammations as well as increasing insulin sensitivity [2].”
Thompson, R. S., Gaffney, M., Hopkins, S., Kelley, T., González, A., Bowers, S. J., Vitaterna, M. H., Turek, F. W., Foxx, C. L., Lowry, C. A., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.006 · Cited by 88
Metadata
- Authors
- Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K.
- Affiliations
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- University of Perugia (IT)
- Intercept Pharmaceuticals (United States) (US)
- Corresponding author
- Auwerx, Johan
- Schoonjans, Kristina
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-08
- Volume
- 7
- Issue
- 8
- Pages
- 678-693
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2078810890
- Cited by
- 1,422
- References
- 169
- Citations by year
- 2026: 81 · 2025: 92 · 2024: 106 · 2023: 107 · 2022: 113 · 2021: 90 · 2020: 83 · 2019: 82 · 2018: 78 · 2017: 81 · 2016: 75 · 2015: 75 · 2014: 71 · 2013: 77 · 2012: 47
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- European Commission
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Société Française de Nutrition
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
- Keywords
- bile acids, bile acid signaling, metabolic disorders, obesity, type 2 diabetes, hypertriglyceridemia, atherosclerosis, nonalcoholic steatohepatitis, therapeutic target, drug development
- MeSH terms
- Animals, Bile Acids and Salts, Humans, Metabolic Diseases, Signal Transduction, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.